vTv Therapeutics Inc (NASDAQ: VTVT) stock enjoyed a major increase of 13.4% on 12/6/24. The shares closed at $17.92. However, trading volume in this advance was unusually low at 60% of normal. The stock has been extremely weak relative to the market over the last nine months but has risen 15.5% during the last week.
Current PriceTarget Research Rating
vTv Therapeutics is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment